« Back
Home /
PARP Antibody

PARP Antibody

Item no.	E10-30016
Manufacturer	Enogene
Amount	100 ug/100 ul
Quantity options	100 ug/100 ul 100 ug/200 ul 100 ug
Category	Oncology Antibodies By Cell Type Carcinoma Hematology Lymphoma Melanoma Sarcoma Cell Biology Cytoskeleton Flow Cytometry Western Blot ELISA Primary Antibodies small GTPases Arf Subfamily
Type	Antibody
Format	Liquid
Applications	WB, FC, ELISA
Specific against	Human (Homo sapiens)
Host	Mouse
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	PARP, PPOL, ADPRT, ADPRT1, PARP-1, pADPRT-1, PARP1
Similar products	PARP
Available
Manufacturer - Applications	WB, FC, ELISA. Not yet tested in other applications.
Manufacturer - Conjugate / Tag	This antibody is also available with the following conjugates: AF350, AF405L, AF405M, AF405S, AF488, AF514, AF532, AF546, AF555, AF568, AF594, AF610, AF635, AF647, AF680, AF700, AF750, AF790, APC, AP, Biotin, Cy3, Cy5.5, Cy5, Cy7, FITC, HRP, PE, Magnetic beads (1 um, 2.8 um, 3 um, 4.5 um, 5 um, 10 um, 15 um, 20 um, 30 um, or different size option) Please contact sales@hoelzel.de for pricing and availability.
Storage Conditions	Store at 4C, for long term storage, store at -20C.
Molecular Weight	117kDa
Immunogen	Synthetic peptide of human PARP, conjugated to KLH.
Research Area	Autophagy antibody, Cancer, Cardiovascular, Cell Biology, Epigenetics and Nuclear Signaling, Developmental Biologys, Immunology, Drug Discovery Products, Metabolism, Neuroscience, Signal Transduction, Stem Cells
Background	This gene encodes a chromatin-associated enzyme, poly(ADP-ribosyl)transferase, which modifies various nuclear proteins by poly(ADP-ribosyl)ation. The modification is dependent on DNA and is involved in the regulation of various important cellular processes such as differentiation, proliferation, and tumor transformation and also in the regulation of the molecular events involved in the recovery of cell from DNA damage. In addition, this enzyme may be the site of mutation in Fanconi anemia, and may participate in the pathophysiology of type I diabetes.
Recommended Dilutions	WB: 1/500 - 1/2000, FC: 1/200-1/400, ELISA: Propose dilution 1/10000.
Formulation Description	Ascitic fluid containing 0.03% sodium azide.
CiteID	EN0013688

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

E10-30016-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 100 ug/100 ul

available

Delivery expected until 9/25/2025

Express Delivery: Save 22 days

Compare

Add to wishlist

Get an offer